PB2031: CD269, CD319 EXPRESSION ON MALIGNANT PLASMA CELLS AND SOLUBLE BCMA, SLAMF7 PROTEINS COMPARATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
A. Startsev(National Medical Research Center for Hematology), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Н. М. Капранов(National Research Center for Preventive Medicine), В. Н. Двирнык, M. N. Panasenko(National Medical Research Center for Hematology), E. A. Makunina, A. Abakumova(National Medical Research Center for Hematology), M. V. Solovev(Ministry of Health of the Russian Federation), Irina Galtseva(National Research Center for Preventive Medicine), М. В. Фирсова(Ministry of Health of the Russian Federation), E. Mamaeva(National Medical Research Center for Hematology)
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59